Protective effects of tiotropium alone or combined with budesonide against cadmium inhalation induced acute neutrophilic pulmonary inflammation in rats
Authors:
Open Access
- 28 February 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (2) , e0193610
Abstract
As a potent bronchodilator, the anti-inflammatory effects of tiotropium and its interaction with budesonide against cadmium-induced acute pulmonary inflammation were investigated. Compared to values obtained in rats exposed to cadmium, cytological analysis indicated a significant decrease of total cell and neutrophil counts and protein concentration in bronchoalveolar lavage fluid (BALF) in rats pretreated with tiotropium (70μg/15ml or 350μg/15ml). Zymographic tests showed a decrease of MMP-2 activity in BALF in rats pretreated only with high concentration of tiotropium. Histological examination revealed a significant decrease of the severity and extent of inflammatory lung injuries in rats pretreated with both tested concentrations of tiotropium. Though tiotropium (70μg/15ml) or budesonide (250μg/15ml) could not reduce cadmium-induced bronchial hyper-responsiveness, their combination significantly decreased bronchial contractile response to methacholine. These two drugs separately decreased the neutrophil number and protein concentration in BALF but no significant interaction was observed when both drugs were combined. Although no inhibitory effects on MMP-2 and MMP-9 was observed in rats pretreated with budesonide alone, the combination with the ineffective dose of tiotropium induced a significant reduction on these parameters. The inhibitory effect of tiotropium on lung injuries was not influenced by budesonide which alone induced a limited action on the severity and extent of inflammatory sites. Our findings show that tiotropium exerts anti-inflammatory effects on cadmium-induced acute neutrophilic pulmonary inflammation. The combination of tiotropium with budesonide inhibits cadmium-induced inflammatory injuries with a synergistic interaction on MMP-2 and MMP-9 activity and airway hyper-responsiveness.Keywords
Funding Information
- National Natural Science Foundation of China (No. 81373468)
This publication has 46 references indexed in Scilit:
- Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 2013
- Bronchoprotection in conscious guinea pigs by budesonide and the NO‐donating analogue, TPI 1020, alone and combined with tiotropium or formoterolBritish Journal of Pharmacology, 2012
- Inhibition of granulocyte migration by tiotropium bromideRespiratory Research, 2011
- Suppression of IL-8 production from airway cells by tiotropium bromide in vitroInternational Journal of Chronic Obstructive Pulmonary Disease, 2011
- Tiotropium bromide inhibits TGF-ß-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitroInternational Journal of Chronic Obstructive Pulmonary Disease, 2010
- Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPDPulmonary Pharmacology & Therapeutics, 2010
- Tiotropium reduction of lung inflammation in a model of chronic gastro-oesophageal refluxEuropean Respiratory Journal, 2009
- Optimising treatment for COPD - new strategies for combination therapyInternational Journal Of Clinical Practice, 2009
- Early short-termversusprolonged low-dose methylprednisolone therapy in acute lung injuryEuropean Respiratory Journal, 2008
- Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smokeJournal of Molecular Medicine, 2008